Massachusetts Institute of Technology chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs more safely and efficiently. Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases.
The Wyss Institute for Biologically Inspired Engineering at Harvard Univ. has received a $5.6 million grant award from the U.S. Food and Drug Administration to use its Organs-on-Chips technology to test human physiological responses to radiation. The project will investigate if the microfluidic devices lined by living human cells can be used instead of animals to evaluate the efficacy and safety of medical treatments for radiation sickness.
A recent invention at Purdue Univ. could improve therapy selection for personalized cancer care. Researchers have created a technique called BioDynamic Imaging that measures the activity inside cancer biopsies, or samples of cells. It allows technicians to assess the efficacy of drug combinations, called regimens, on personal cancers.
Lawrence Berkeley National Laboratory scientists have helped to develop a tiny chip that has big potential for quickly determining whether someone has been exposed to dangerous levels of ionizing radiation. The first-of-its-kind chip has an array of nanosensors that measure the concentrations of proteins that change after radiation exposure.
A team of researchers in Singapore and South Korea have developed a fluorescent caffeine detector and a detection kit that lights up like a traffic light when caffeine is present in various drinks and solutions. Based on a technology called “lab-on-a-disc”, the detection system identifies caffeine concentrations using laser light.
At Battelle, supporting America’s military personnel is woven into the fabric of its business. In that pursuit, a team consisting of Battelle, NxStage Medical Inc. and Aethlon Medical has won a contract from DARPA to develop an innovative, new medical device that may save the lives of soldiers—and civilians as well—by treating sepsis.
Univ. of Maryland Ventures announced agreements between Univ. of Maryland, Baltimore and five different life sciences companies across the Baltimore/Washington metropolitan region. The companies include Rexahn Pharmaceuticals, Plasmonix, IGI Technologies, A&G Pharmaceuticals and BioAssay Works.
Early in 2012, a team of scientists reported the development of a postage stamp-sized microchip capable of sorting cells through a technique, known as cell rolling, that mimics a natural mechanism in the body. The device successfully separated leukemia cells from cell cultures, but could not extract cells directly from blood. Now the group has developed a new microchip that can quickly separate white blood cells from samples of whole blood.
Using imperfections in diamonds as nanoscale thermometers, and gold nanoparticles implanted in cells as laser-induced heating mechanisms, a team of researchers working on DARPA’s Quantum-Assisted Sensing and Readout program recently demonstrated sub-degree temperature measurement and control at the nanometer scale inside living cells.
Reaching a clinic in time to receive an early diagnosis for cancer—when the disease is most treatable—is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
Afraid there may be peanuts or other allergens hiding in that cookie? Thanks to a cradle and app that turn your smartphone into a handheld biosensor, you may soon be able to run on-the-spot tests for food safety, environmental toxins, medical diagnostics and more.
A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other “extreme” athletes that they’re about to “bonk,” or “hit the wall.” The study describes the first human tests of the sensor, which also could help soldiers and others who engage in intense exercise.
Engineers at the Massachusetts Institute of Technology have developed a rapid and highly efficient system for transferring large molecules, nanoparticles, and other agents into living cells, providing new avenues for disease research and treatment. The high throughput method treats up to 100,000 cells per second and uses controlled mechanical force that is non-toxic to cells.
The electrical activity of neurons contains a mixture of stored memories, environmental circumstances, and current state of mind, scientists have found in a study of laboratory rats. The research, which monitored neuronal electrical activity in the hippocampus, relied on the concept of “cross-episode retrieval”, in which brain activity is stimulated in a given circumstance that was also activated in a previous, distinctive experience.
Scientists have developed an "intelligent knife" that can tell surgeons immediately whether the tissue they are cutting is cancerous or not. In the first study to test the invention in the operating theatre, the "iKnife" diagnosed tissue samples from 91 patients with 100% accuracy, instantly providing information that normally takes up to half an hour to reveal using laboratory tests.
More than 3.5 billion years ago, meteors ricocheted around the solar system, passing material between Mars and Earth. This may have left bits of Earth on Mars, and vice versa, creating a shared genetic ancestry. Now, a team of researchers is building a DNA sequencer that he hopes will one day be sent to Mars, where it can analyze soil and ice samples for traces of DNA and other genetic material.
In new research, Biodesign Institute team members describe a pair of tweezers made using principles of DNA base-pairing. They are astonishingly small: When the jaws of these tools are in the open position, the distance between the two arms is about 16 nanometers—over 30,000 times smaller than a single grain of sand.
DNA sometimes twists itself into supercoils, an phenomenon caused by enzymes that travel along DNA’s helical groove and exert force and torque as they move. For the first time, these tiny torques have been measured using an instrument called an angular optical trap. Researchers at Cornell University have reported direct measurements of the torque generated by a motor protein as it traverses supercoiled DNA.
Marya Lieberman, assoc. prof. of chemistry and biochemistry at the Univ. of Notre Dame, and her collaborators have recently published results that show the effectiveness of an inexpensive paper test card that could fundamentally change the balance of power between pharmaceutical buyers and sellers in the developing world.
Comic book hero Popeye swears by it. And so do generations of parents who “spoil” their children with spinach. But too much iron content in the blood can indicate acute inflammatory responses, which makes it an important medical diagnostic agent. Using nanoscale diamonds which feature defects, researchers in Europe have developed a new, sensitive biosensor for determination of iron content.
Scientists at the University of Texas at San Antonio and the U.S. Army Institute of Surgical Research have developed a microarray platform for culturing fungal biofilms that holds 1,200 individual cultures of fungi or bacteria. The nano-scale platform technology could one day be used for rapid drug discovery for treatment of any number of fungal or bacterial infections, or even as a rapid clinical test to identify antibiotic drugs.
Imagine a swarm of tiny devices only a few hundred nanometers in size that can detect trace amounts of toxins in a water supply or the very earliest signs of cancer in the blood. Now imagine that these tiny sensors can reset themselves, allowing for repeated use over time inside a body of water—or a human body. In a recent Yale Univ. breakthrough, this has become a reality.
A research team at New Jersey Institute of Technology have created a carbon nanotube-based device to noninvasively and quickly detect mobile single cells with the potential to maintain a high degree of spatial resolution. This prototype lab-on-a-chip could someday enable a physician to detect disease or virus from just one drop of liquid, including blood.
Duke Univ. biomedical engineers and genome researchers have developed a proof-of-principle approach using light to detect infections before patients show symptoms. The approach was demonstrated in human samples, and researchers are now developing the technique for placement on a chip, which could provide fast, simple and reliable information about a patient. A diagnostic device based on this chip also could be made portable.
The Food and Drug Administration on Thursday approved the first blood test that can identify different strains of the hepatitis C virus to help guide a patient's treatment. Abbot Laboratories Inc.'s RealTime HCV Genotype II test is designed to figure out the strain of the virus in patients who are already known to have hepatitis C rather than diagnosing patients with the virus itself.